» Articles » PMID: 28701492

Behavioral-variant Frontotemporal Dementia: Distinct Phenotypes with Unique Functional Profiles

Overview
Journal Neurology
Specialty Neurology
Date 2017 Jul 14
PMID 28701492
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To identify distinct behavioral phenotypes of behavioral-variant frontotemporal dementia (bvFTD) and to elucidate differences in functional, neuroimaging, and progression to residential care placement.

Methods: Eighty-eight patients with bvFTD were included in a cluster analysis applying levels of disinhibition and apathy (Cambridge Behavioural Inventory-Revised) to identify phenotypic subgroups. Between-group (Kruskal-Wallis, Mann-Whitney ) functional differences (Disability Assessment for Dementia) and time to residential care placement (survival analyses) were examined. Cortical thickness differences (whole-brain MRI) were analyzed in patients with bvFTD vs healthy controls (n = 30) and between phenotypic subgroups.

Results: Four phenotypic subgroups were identified: primary severe apathy (n = 26), severe apathy and disinhibition (n = 26), mild apathy and disinhibition (n = 27), and primary severe disinhibition (n = 9). Patients with severely apathetic phenotypes were more functionally impaired and had more extensive brain atrophy than those with mild apathy or severe disinhibition alone. Further imaging analyses indicated that the right middle temporal region is critical for the development of disinhibition, an association that remains with disease progression and in the context of severe apathy. Finally, no difference in time to residential care admission was found between phenotypes.

Conclusions: This study reveals that different clinical behavioral phenotypes of bvFTD have differing profiles of functional decline and distinct patterns of associated cortical changes. These findings emphasize the importance of apathy in functional impairment, highlight the role of the right temporal region in disinhibition, and suggest that disability may be a sensitive outcome measure for treatments targeting reduction of apathy. These phenotypes could also support understanding of prognosis and clinical management.

Citing Articles

A structural MRI marker predicts individual differences in impulsivity and classifies patients with behavioral-variant frontotemporal dementia from matched controls.

Godefroy V, Durand A, Simon M, Weber B, Kable J, Lerman C bioRxiv. 2024; .

PMID: 39345385 PMC: 11429931. DOI: 10.1101/2024.09.12.612706.


Rehabilitation Services for Young-Onset Dementia: Examples from High- and Low-Middle-Income Countries.

Suarez-Gonzalez A, Savage S, Alladi S, Amaral-Carvalho V, Arshad F, Camino J Int J Environ Res Public Health. 2024; 21(6).

PMID: 38929036 PMC: 11203756. DOI: 10.3390/ijerph21060790.


The pursuit for markers of disease progression in behavioral variant frontotemporal dementia: a scoping review to optimize outcome measures for clinical trials.

Fieldhouse J, van Paassen D, van Engelen M, de Boer S, Hartog W, Braak S Front Aging Neurosci. 2024; 16:1382593.

PMID: 38784446 PMC: 11112081. DOI: 10.3389/fnagi.2024.1382593.


Profiles of motivational impairment and their relationship to functional decline in frontotemporal dementia.

Shaw S, Horne K, Piguet O, Ahmed R, Whitton A, Irish M J Neurol. 2024; 271(8):4963-4971.

PMID: 38758282 PMC: 11319612. DOI: 10.1007/s00415-024-12430-0.


Atrophy network mapping of clinical subtypes and main symptoms in frontotemporal dementia.

Chu M, Jiang D, Li D, Yan S, Liu L, Nan H Brain. 2024; 147(9):3048-3058.

PMID: 38426222 PMC: 11370799. DOI: 10.1093/brain/awae067.


References
1.
Gelinas I, Gauthier L, McIntyre M, Gauthier S . Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia. Am J Occup Ther. 1999; 53(5):471-81. DOI: 10.5014/ajot.53.5.471. View

2.
Snowden J, Bathgate D, Varma A, Blackshaw A, Gibbons Z, Neary D . Distinct behavioural profiles in frontotemporal dementia and semantic dementia. J Neurol Neurosurg Psychiatry. 2001; 70(3):323-32. PMC: 1737271. DOI: 10.1136/jnnp.70.3.323. View

3.
Franceschi M, Anchisi D, Pelati O, Zuffi M, Matarrese M, Moresco R . Glucose metabolism and serotonin receptors in the frontotemporal lobe degeneration. Ann Neurol. 2005; 57(2):216-25. DOI: 10.1002/ana.20365. View

4.
de Vugt M, Stevens F, Aalten P, Lousberg R, Jaspers N, Verhey F . A prospective study of the effects of behavioral symptoms on the institutionalization of patients with dementia. Int Psychogeriatr. 2005; 17(4):577-89. DOI: 10.1017/S1041610205002292. View

5.
Peters F, Perani D, Herholz K, Holthoff V, Beuthien-Baumann B, Sorbi S . Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia. Dement Geriatr Cogn Disord. 2006; 21(5-6):373-9. DOI: 10.1159/000091898. View